GRAIL Inc

GRALNASDAQ · USD
108.69USD+27.92 (+34.57%)
2510

GRAIL Inc (GRAL) Covered Calls

As of September 18, 2026, GRAL has 58 covered call opportunities in the coming three months. Return ranges from 15.0 to 118.5% until expiration. Annualized return ranges from 29.7 to 957.5%. The nearest expiration is October 16, 2026. Maximum potential profit is $9,573.

Read more

Running GRAL covered calls helps you generate consistent income from GRAIL Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on GRAIL Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best GRAL covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if GRAL stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling GRAL covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given GRAIL Inc covered call is worth writing.

GRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. It is also developing minimal residual disease and other post-diagnostic tests. The company was incorporated in 2015 and is based in Menlo Park, California. GRAIL, Inc. operates as a former subsidiary of Illumina, Inc.

Income-focused investors, long-term GRAL holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling GRAL covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best GRAIL Inc covered calls come to you, already filtered for the metrics that matter.

Stock Statistics

  • IndustryDiagnostics & Research
  • SectorHealthcare
  • IV percentile99.60% Elevated
  • Market cap (M$)3,608
  • 52 weeks high-32.03%
  • 52 weeks low94.63%
  • Analyst recommendationBuy
    2.18
  • Target price$77.70
    -29.16% below the current stock price
  • Dividend
  • Payout ratio
  • Earnings date2026-11-11
  • P/E
  • Future P/E
  • EPS (ttm)-9.75
  • EPS growth next 5 years4.45%

As of September 18, 2026

2026-10-1628140.0073.330.102.605933.0073.46957.54-0.12+0.11122.50
2026-10-1628130.0060.950.551.204978.0061.63803.41-0.68+0.094780.65
2026-10-1628125.0054.760.701.754493.0055.63725.14-0.87+0.11471.05
2026-10-1628115.0042.381.453.003568.0044.17575.85-1.80+0.185131.55
2026-10-1628110.0036.191.903.203113.0038.54502.42-2.35+0.21791.30
2026-10-1628105.0030.003.004.802723.0033.71439.47-3.71+0.27371.80
2026-10-1628100.0023.813.505.002273.0028.14366.85-4.33+0.312,3731.50
2027-01-15119165.00104.281.502.608573.00106.14325.56-1.86+0.12841.10
2027-01-15119160.0098.090.203.107943.0098.34301.63-0.25+0.11762.90
2026-10-162895.0017.624.106.801833.0022.69295.83-5.08+0.371282.70

As of September 18, 2026

Sell covered calls with the data behind you

Find the best GRAL covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.

Start your 14-day free trial